Longitude Prize launches new seed funding to drive innovation in rapid tests to help reduce antibiotic resistance
-Discovery Awards programme offers up to £25,000 to help teams overcome barriers to develop game-changing rapid tests and to win the £10m Longitude Prize
-Grant funding comes from MSD, known as Merck in the United States and Canada, at a time when current trends project antimicrobial resistance will cause 10 million deaths annually by 2050
Davos-Klosters, Switzerland - 20 January: At a panel event about diagnostics and global antimicrobial resistance (AMR), taking place at the World Economic Forum’s Annual Meeting in Davos today, the UK’s Chief Medical Officer Professor Dame Sally Davies announces £250,000 of Discovery Award seed funding for diagnostic tests that could win the Longitude Prize.
Now in its third year of five, the Longitude Prize is a £10 million prize challenge to create a cost-effective, accurate, rapid,...
